Literature DB >> 12049725

The dispersal of mucosal memory B cells: evidence from persistent EBV infection.

Lauri L Laichalk1, Donna Hochberg, Gregory J Babcock, Richard B Freeman, David A Thorley-Lawson.   

Abstract

We have used latent infection with the human herpesvirus Epstein-Barr virus to track the dispersal of memory B cells from the mucosal lymphoid tissue of Waldeyer's ring (tonsils/adenoids). EBV is evenly distributed between the memory compartments of Waldeyer's ring and the peripheral blood. However, it has an approximately 20-fold higher preference for Waldeyer's ring over the spleen or mesenteric lymph nodes. These observations are consistent with a model whereby the virus preferentially establishes persistent infection within memory B cells from Waldeyer's ring. The virus then colonizes the entire peripheral lymphoid system, at a low level, by trafficking with these memory B cells as they circulate through the body and back to Waldeyer's ring. This pathway may reflect that of normal memory B cells derived from nasopharyngeal and other mucosal lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12049725     DOI: 10.1016/s1074-7613(02)00318-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  55 in total

1.  Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

Authors:  Donna Hochberg; Jaap M Middeldorp; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

2.  Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.

Authors:  Donna Hochberg; Tatyana Souza; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 3.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

Review 4.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 5.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.

Authors:  Nicolae Balan; Kay Osborn; Alison J Sinclair
Journal:  J Gen Virol       Date:  2015-12-11       Impact factor: 3.891

7.  Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.

Authors:  Lauri L Laichalk; David A Thorley-Lawson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis.

Authors:  Vey Hadinoto; Michael Shapiro; Thomas C Greenough; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

9.  Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection.

Authors:  Barbro Ehlin-Henriksson; Wu Liang; Alberto Cagigi; Frida Mowafi; George Klein; Anna Nilsson
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

10.  The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output.

Authors:  Vey Hadinoto; Michael Shapiro; Chia Chi Sun; David A Thorley-Lawson
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.